Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to -$365000.0.

  • Merit Medical Systems' Cash from Financing Activities rose 9923.28% to -$365000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.4 million, marking a year-over-year decrease of 9674.22%. This contributed to the annual value of -$60.0 million for FY2024, which is 11072.98% down from last year.
  • Per Merit Medical Systems' latest filing, its Cash from Financing Activities stood at -$365000.0 for Q3 2025, which was up 9923.28% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, Merit Medical Systems' Cash from Financing Activities registered a high of $472.8 million during Q4 2023, and its lowest value of -$54.6 million during Q3 2023.
  • For the 5-year period, Merit Medical Systems' Cash from Financing Activities averaged around $18.5 million, with its median value being -$13.2 million (2022).
  • Per our database at Business Quant, Merit Medical Systems' Cash from Financing Activities soared by 832421.29% in 2023 and then plummeted by 352233.4% in 2024.
  • Merit Medical Systems' Cash from Financing Activities (Quarter) stood at -$32.5 million in 2021, then surged by 82.29% to -$5.7 million in 2022, then soared by 8324.21% to $472.8 million in 2023, then plummeted by 99.49% to $2.4 million in 2024, then plummeted by 115.01% to -$365000.0 in 2025.
  • Its Cash from Financing Activities stands at -$365000.0 for Q3 2025, versus $4.3 million for Q2 2025 and $7.0 million for Q1 2025.